Clinical Trials Directory

Trials / Completed

CompletedNCT04480437

Multi-parametric Breast Ultrasound Imaging as a Potential Biomarker for Breast Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Swiss Federal Institute of Technology · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

It is studied whether multi-parametric biomarkers such as speed-of-sound imaging or others, applied during breast ultrasound (BUS) imaging allows to classify lesions according to its malignancy. The standard reference intervention is BUS guided biopsy or the consensus of the board of experts judging the BUS imaging results if no biopsy is done.

Detailed description

Patients with a palpable lump in the breast or suspicious findings in X-ray mammography typically undergo breast ultrasound examination as a supplemental imaging modality. Findings are then used for tumour classification according the American Collage of Radiology (ACR) Breast Imaging Reporting and Database System (BI-RADS) lexicon. Suspicious findings then undergo ultrasound-guided biopsy, which causes discomfort for the patient and introduces high emotional stress, and may involve - albeit very-small - risk of complications (such as bleeding and infections). Today conventional breast ultrasound B-mode images do not have the specificity to reliably differentiate malignant and benign tissues in all cases and hence a biopsy intervention or close follow-up is necessitated. Multiparametric imaging bio-markers such as the novel method of speed-of-sound imaging may provide additional indicators to help to better classify lesions prior to biopsy and avoid any further work-up. The study collects data with an ultrasound device during normal BUS examination which is then retrospectively processed to extract the desired multi-parametric BUS (mp-BUS) information of imaged tissue.

Conditions

Interventions

TypeNameDescription
DEVICEmp-BUS data collectionCollect ultrasound raw data and B-mode images of all kind of breast lesions to external storage device.

Timeline

Start date
2020-11-15
Primary completion
2021-12-13
Completion
2021-12-13
First posted
2020-07-21
Last updated
2021-12-28

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04480437. Inclusion in this directory is not an endorsement.